Skip to main content

TRAVERSE Trial

Meaning

The TRAVERSE Trial, formally the Testosterone Replacement Therapy for Assessment of Long-term Vascular Events and Safety trial, is a large-scale, randomized, placebo-controlled clinical trial designed to rigorously evaluate the long-term cardiovascular safety of testosterone replacement therapy (TRT) in men with hypogonadism. This landmark study addresses a critical clinical question regarding the potential risks and benefits of TRT on major adverse cardiovascular events (MACE), including non-fatal myocardial infarction, non-fatal stroke, and cardiovascular death. Its findings are essential for guiding clinical practice and risk stratification in men receiving hormonal optimization.